BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27566994)

  • 1. The Neurological Predictor Scale: A predictive tool for long-term core cognitive outcomes in survivors of childhood brain tumors.
    Taiwo Z; Na S; King TZ
    Pediatr Blood Cancer; 2017 Jan; 64(1):172-179. PubMed ID: 27566994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral processing speed as a key mechanism in the relationship between neurological risk and adaptive functioning in survivors of pediatric brain tumors.
    Semmel ES; Quadri TR; King TZ
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28575. PubMed ID: 32813316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood brain tumor.
    McCurdy MD; Rane S; Daly BP; Jacobson LA
    J Neurooncol; 2016 Mar; 127(1):137-44. PubMed ID: 26725098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental model of long-term outcomes of adult survivors of childhood brain tumors.
    King TZ; Ailion AS; Fox ME; Hufstetler SM
    Child Neuropsychol; 2019 Jan; 25(1):1-21. PubMed ID: 28956496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Formula: see text]Cumulative neurological factors associated with long-term outcomes in adult survivors of childhood brain tumors.
    King TZ; Na S
    Child Neuropsychol; 2016; 22(6):748-60. PubMed ID: 26069903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological predictor scale is associated with academic achievement outcomes in long-term survivors of childhood brain tumors.
    Kautiainen RJ; Na SD; King TZ
    J Neurooncol; 2019 Mar; 142(1):193-201. PubMed ID: 30607706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting neuropsychological late effects in pediatric brain tumor survivors using the Neurological Predictor Scale and the Pediatric Neuro-Oncology Rating of Treatment Intensity.
    Srsich AR; McCurdy MD; Fantozzi PM; Hocking MC
    J Int Neuropsychol Soc; 2024 May; 30(4):380-388. PubMed ID: 37746790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial.
    Conklin HM; Ogg RJ; Ashford JM; Scoggins MA; Zou P; Clark KN; Martin-Elbahesh K; Hardy KK; Merchant TE; Jeha S; Huang L; Zhang H
    J Clin Oncol; 2015 Nov; 33(33):3894-902. PubMed ID: 26460306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Underpinnings of Working Memory in Adult Survivors of Childhood Brain Tumors.
    King TZ; Na S; Mao H
    J Int Neuropsychol Soc; 2015 Aug; 21(7):494-505. PubMed ID: 26234757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Attention Problems on Psychosocial Functioning in Childhood Brain Tumor Survivors: A 2-Year Postcraniospinal Irradiation Follow-up.
    Oh Y; Seo H; Sung KW; Joung YS
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e46-e53. PubMed ID: 28099397
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kautiainen RJ; Dwivedi B; MacDonald TJ; King TZ
    Child Neuropsychol; 2020 Aug; 26(6):739-753. PubMed ID: 32054423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive functioning in pediatric craniopharyngioma: performance before treatment with proton therapy.
    Fournier-Goodnight AS; Ashford JM; Merchant TE; Boop FA; Indelicato DJ; Wang L; Zhang H; Conklin HM
    J Neurooncol; 2017 Aug; 134(1):97-105. PubMed ID: 28540667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cognitive sequelae after pediatric brain tumor related to medical risk factors, age, and sex.
    Tonning Olsson I; Perrin S; Lundgren J; Hjorth L; Johanson A
    Pediatr Neurol; 2014 Oct; 51(4):515-21. PubMed ID: 25266614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the General Ability Index (GAI) and Cognitive Proficiency Index (CPI) with survivors of pediatric brain tumors: Comparison to Full Scale IQ and premorbid IQ estimates.
    Kahalley LS; Winter-Greenberg A; Stancel H; Ris MD; Gragert M
    J Clin Exp Neuropsychol; 2016 Dec; 38(10):1065-76. PubMed ID: 27295192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood.
    Aarsen FK; Paquier PF; Arts WF; Van Veelen ML; Michiels E; Lequin M; Catsman-Berrevoets CE
    J Clin Oncol; 2009 Jul; 27(21):3526-32. PubMed ID: 19433687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors.
    Reimers TS; Ehrenfels S; Mortensen EL; Schmiegelow M; Sønderkaer S; Carstensen H; Schmiegelow K; Müller J
    Med Pediatr Oncol; 2003 Jan; 40(1):26-34. PubMed ID: 12426683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.